Antimalarial · Artemisinin-based combination therapy
Artesunate and amodiaquine tablets
A fixed-dose combination for uncomplicated malaria, widely used in West and Central Africa. Progene Pharma supplies artesunate and amodiaquine as tablets in adult and paediatric strengths, packed by weight band, under your brand and with the documents you need to register it.
- Forms
- Tablets
- Strengths
- 3 options
- Supply
- Private label or ready brand
- Documents
- COA, COPP, MSDS, dossier
Available strengths
Artesunate / amodiaquine in each tablet. Packs by weight band, and other strengths approved in your country, are made to order. Pack sizes and labelling are made to match your registration.
-
25 / 67.5 mg
Tablet
For infants, the lowest weight band
-
50 / 135 mg
Tablet
For young children
-
100 / 270 mg
Tablet
For older children and adults
About artesunate and amodiaquine
What it treats
Artesunate and amodiaquine is used to treat uncomplicated malaria caused by Plasmodium falciparum. It is an artemisinin-based combination therapy (ACT), the type of treatment the World Health Organization recommends for this kind of malaria. It is a first-line treatment in many African countries, especially in West and Central Africa, and it is on the WHO Model List of Essential Medicines.
Why two medicines in one
Artesunate acts quickly and brings parasite numbers down sharply, and amodiaquine stays in the body longer to clear the rest. A fixed-dose tablet means the patient takes both together, which makes treatment simpler and more reliable than taking two separate medicines.
How it is taken
Treatment is a short course over three days, once a day, with the dose set by body weight, and the tablets are packed in strengths for each weight band. It is not a treatment for severe malaria, which starts with injectable artesunate. Amodiaquine is not suitable for everyone, including people with liver problems, so patients should always follow the approved label in their country.
Prescription medicine. This information is for distributors and healthcare professionals and is not medical advice.
Made for your market
Registration rules differ from country to country. We build the product around yours.
-
Private label
Your brand name on the carton, blister foil and leaflet, designed to your regulator's rules.
-
Packaging
Pack sizes, languages and artwork to suit how the medicine is prescribed and sold in your country.
-
Registration documents
COPP, MSDS and the product dossier for registration, and a COA with every batch.
-
Certified manufacturing
Manufactured in a facility certified to WHO-GMP, EU-GMP and ISO. What each standard means
How ordering works
-
01
Tell us what you need
The strength, pack size, quantity and the country you are registering in.
-
02
Quotation and documents
We confirm price, lead time and the certification and paperwork your regulator expects.
-
03
Manufacture and testing
Manufactured in a certified facility. Every batch is tested and released with a COA.
-
04
Shipping
Packed for export and shipped with the documents you need for import clearance.
Other antimalarials we supply
Ask for any of these with your quotation, or see the full product list.
-
Tablets 20/120 to 80/480 mg; dispersible tablets; dry syrup
-
Injection 60 mg; tablets 50, 100 and 200 mg
-
Dihydroartemisinin and piperaquine
Tablets 40/320 mg; dry syrup
-
Tablets 500/25 mg
-
Injection 300 mg and 600 mg; tablets
Questions about artesunate and amodiaquine
Something else? Email [email protected].
Which strengths of artesunate and amodiaquine do you supply?
Tablets of 25 mg / 67.5 mg, 50 mg / 135 mg and 100 mg / 270 mg, packed by weight band. Other strengths approved in your country can be made to order, and pack sizes and labelling are made to match your registration.
Do you make paediatric packs?
Yes. The 25 mg / 67.5 mg and 50 mg / 135 mg tablets are made for infants and young children, and we pack each weight band in the course length your guidelines use.
Is it used for seasonal malaria chemoprevention?
Amodiaquine is also used with sulfadoxine and pyrimethamine for seasonal malaria chemoprevention in children in some regions. That is a different product and pack from this combination, and we can supply both. Tell us the programme's specification and we will confirm what we can provide.
Can you supply it under our own brand?
Yes. Progene Pharma manufactures it as a private label product, with the carton, blister foil or label and patient leaflet designed for your market and your regulator's requirements.
Which documents come with it?
Every batch ships with a Certificate of Analysis (COA). Progene Pharma also provides the Certificate of Pharmaceutical Product (COPP), MSDS and the product dossier you need to register and import it.
Where is it manufactured?
Progene Pharma manufactures it in a WHO-GMP certified facility in India, also certified to EU-GMP and ISO standards. Tell us your destination country and we will confirm which certification applies to your order.
What is the minimum order quantity and lead time?
Both depend on the strength, pack size and documents your market needs. We confirm them with your quotation, and we work with large importers as well as smaller distributors.
Related pages
- Antimalarials
- Dihydroartemisinin and piperaquine
- Sulfadoxine and pyrimethamine
- Quinine
- Artemether and lumefantrine
- Private label artesunate and amodiaquine
- Export documentation
- Artesunate and amodiaquine export to Africa
- Artesunate and amodiaquine export to Latin America
- Artesunate and amodiaquine export to Southeast Asia
- Markets we supply
Request a quote
Send us your product requirements and target country. Our team will reply with a quotation and next steps.
- [email protected]
- Phone
- +91 22 49793146
- +91 90829 70494